Read through the following Frequently Asked Questions about PSMA theranostics:
PSMA theranostics resources
PSMA theranostics is a treatment that we are increasingly using for people with advanced prostate cancer. It is also the focus of the world-leading research at our Prostate Theranostics and Imaging Centre of Excellence. This therapy aims to reduce the size of tumours and to stop them from multiplying, as well as to ease the symptoms that people may get
The first thing you need to do is speak to your oncologist about whether this treatment is right for you.
We are conducting several trials of lutetium PSMA treatment for prostate cancer, and there may be a clinical trial suited to you.
Discuss this with your oncologist, who can seek out information on the trials and who can refer you to Peter Mac if you are suitable.
The first thing you need to do is speak to your oncologist about whether this treatment is right for you.
There may be options for accessing this treatment in your state.
We are offering lutetium PSMA treatment to men via clinical trials, and we may have a clinical trial suited to you.
You may be able to enrol in these trials at a hospital or treatment centre in your state.
Discuss this with your oncologist, who can seek out information on the trials and who can refer you to us or a centre in your state if you are suitable.
You would need to travel to Peter Mac in Melbourne to receive the treatment.
It’s important to not make any changes to your treatment plan without first speaking to your oncologist.
Your oncologist can seek out information on the lutetium PSMA trials underway at Peter Mac, and whether these are suitable for you in an appropriate timeframe.
Any patient with a Medicare card can come to us for a second opinion about their prostate cancer treatment.
Speak to your oncologist about getting a referral. There is more information about being referred on our Getting started page.